These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 31772015)
1. MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome. Emgård J; Bergsten H; McCormick JK; Barrantes I; Skrede S; Sandberg JK; Norrby-Teglund A Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25923-25931. PubMed ID: 31772015 [TBL] [Abstract][Full Text] [Related]
2. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression. Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753 [TBL] [Abstract][Full Text] [Related]
3. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens. Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800 [TBL] [Abstract][Full Text] [Related]
4. MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection. Paquin-Proulx D; Avelino-Silva VI; Santos BAN; Silveira Barsotti N; Siroma F; Fernandes Ramos J; Coracini Tonacio A; Song A; Maestri A; Barros Cerqueira N; Felix AC; Levi JE; Greenspun BC; de Mulder Rougvie M; Rosenberg MG; Nixon DF; Kallas EG PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006154. PubMed ID: 29357366 [TBL] [Abstract][Full Text] [Related]
5. Alcohol Abstinence Does Not Fully Reverse Abnormalities of Mucosal-Associated Invariant T Cells in the Blood of Patients With Alcoholic Hepatitis. Li W; Lin EL; Liangpunsakul S; Lan J; Chalasani S; Rane S; Puri P; Kamath PS; Sanyal AJ; Shah VH; Radaeva S; Crabb DW; Chalasani N; Yu Q Clin Transl Gastroenterol; 2019 Jun; 10(6):e00052. PubMed ID: 31211759 [TBL] [Abstract][Full Text] [Related]
6. IL-33 Enhances IFNγ and TNFα Production by Human MAIT Cells: A New Pro-Th1 Effect of IL-33. Azzout M; Dietrich C; Machavoine F; Gastineau P; Bottier A; Lezmi G; Leite-de-Moraes M Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638950 [TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen class II haplotypes that protect against or predispose to streptococcal toxic shock. Llewelyn M Clin Infect Dis; 2005 Nov; 41 Suppl 7():S445-8. PubMed ID: 16237645 [TBL] [Abstract][Full Text] [Related]
9. Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: implications for customized patient care. Nooh MM; Nookala S; Kansal R; Kotb M J Immunol; 2011 Mar; 186(5):3156-63. PubMed ID: 21282506 [TBL] [Abstract][Full Text] [Related]
10. The contribution of group A streptococcal virulence determinants to the pathogenesis of sepsis. Reglinski M; Sriskandan S Virulence; 2014 Jan; 5(1):127-36. PubMed ID: 24157731 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Müller-Alouf H; Alouf JE; Gerlach D; Ozegowski JH; Fitting C; Cavaillon JM Infect Immun; 1994 Nov; 62(11):4915-21. PubMed ID: 7927772 [TBL] [Abstract][Full Text] [Related]
12. Contribution of APCs to mucosal-associated invariant T cell activation in infectious disease and cancer. Shey MS; Balfour A; Wilkinson KA; Meintjes G Innate Immun; 2018 May; 24(4):192-202. PubMed ID: 29631470 [TBL] [Abstract][Full Text] [Related]
13. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Sriskandan S; Faulkner L; Hopkins P Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999 [TBL] [Abstract][Full Text] [Related]
14. Production of IL-17 by MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with IL-7 Receptor Expression. Willing A; Jäger J; Reinhardt S; Kursawe N; Friese MA J Immunol; 2018 Feb; 200(3):974-982. PubMed ID: 29298833 [TBL] [Abstract][Full Text] [Related]
15. Tuning of human MAIT cell activation by commensal bacteria species and MR1-dependent T-cell presentation. Tastan C; Karhan E; Zhou W; Fleming E; Voigt AY; Yao X; Wang L; Horne M; Placek L; Kozhaya L; Oh J; Unutmaz D Mucosal Immunol; 2018 Nov; 11(6):1591-1605. PubMed ID: 30115998 [TBL] [Abstract][Full Text] [Related]
16. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000 [TBL] [Abstract][Full Text] [Related]
17. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells. Zumwalde NA; Haag JD; Gould MN; Gumperz JE Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917 [TBL] [Abstract][Full Text] [Related]
18. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Chen Z; Wang H; D'Souza C; Sun S; Kostenko L; Eckle SB; Meehan BS; Jackson DC; Strugnell RA; Cao H; Wang N; Fairlie DP; Liu L; Godfrey DI; Rossjohn J; McCluskey J; Corbett AJ Mucosal Immunol; 2017 Jan; 10(1):58-68. PubMed ID: 27143301 [TBL] [Abstract][Full Text] [Related]
19. Human liver CD8 Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824 [TBL] [Abstract][Full Text] [Related]
20. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. Watanabe-Ohnishi R; Low DE; McGeer A; Stevens DL; Schlievert PM; Newton D; Schwartz B; Kreiswirth B; Kotb M J Infect Dis; 1995 Jan; 171(1):74-84. PubMed ID: 7798684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]